We hypothesized that women with PCOS would exhibit elevated insulin, HOMA-IR, LH, AMH, and inflammatory markers, serving as robust predictors for clinical diagnosis, with phenotype-specific metabolic variations, particularly in insulin resistance and electrolyte balance. Here, AMH is linked to polycystic ovary syndrome.